Novavax appoints new VP of pharma development

Sep. 9, 2005 – Novavax Inc. announced the appointment of Robert Lee to the position of vice president of pharmaceutical development. Lee will report directly to Rahul Singhvi, president and CEO.

Lee, 45, joins Novavax following 15 years in pharma research and development of therapeutic drugs and diagnostic imaging agents. Most recently he was vice president of product development for Lyotropic Therapeutics Inc. in Ashland, Va.

From 1990 to 2002, Lee held various research & development positions with Sterling Winthrop Pharmaceuticals, NanoSystems, and elan Drug Delivery Inc. His areas of expertise include preformulation, drug delivery, formulation development, analytical sciences, sterile manufacturing, and technology evaluation and development. He was one of the founders of NanoSystems.

Novavax is attempting to develop products using a proprietary micellar nanoparticle technology.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.